ITGAD and brain injury: Taken together, these findings suggest that infiltrating leukocytes increase neuroinflammation, secondary brain damage, and functional impairment in a repeated concussion setting, and that the anti-CD11d mAb holds promise as a novel treatment to limit these effects.